Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Multicentre, Randomised, Comparative, Prospective Trial With MD-3511356 Versus Standard Sun Protection Measures in Immunosuppressed Solid Organ Transplanted Patients for Prevention of UV-induced Carcinogenic Skin Alterations

NCT01532453 is registered in ClinicalTrials.gov with Spirig Pharma Ltd. as lead sponsor.

NCT NCT01532453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01532453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Multicentre, Randomised, Comparative, Prospective Trial With MD-3511356 Versus Standard Sun Protection Measures in Immunosuppressed Solid Organ Transplanted Patients for Prevention of UV-induced Carcinogenic Skin Alterations
Lead sponsor
Spirig Pharma Ltd.
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2010
Completion date
January 31, 2014
Enrollment
244 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratoses, squamous cell carcinomas